Gene: MAGI3

260425
MAGI-3|dJ730K3.2
membrane associated guanylate kinase, WW and PDZ domain containing 3
protein-coding
1p13.2
Ensembl:ENSG00000081026 MIM:615943 Vega:OTTHUMG00000011737 UniprotKB:Q5TCQ9
NC_000001.11
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
5.586e-1 (AD)  2.788e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PPM1L0.964
GSK3B0.958
GMPS0.948
SYNJ10.947
VPS350.946
MTMR90.946
WDR470.945
DMXL20.945
KRAS0.945
ATP6V1A0.943

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CSAG1-0.462
OR4F5-0.454
HEY2-0.443
RAB13-0.437
MYL3-0.421
ROM1-0.42
RAI14-0.419
MDFI-0.412
BCL7C-0.411
OR4F29-0.41

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MAGI3 mRNA19933214
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of MAGI3 mRNA"21346803
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAGI3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAGI3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAGI3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAGI3 mRNA"27188386
D000082AcetaminophenAcetaminophen affects the expression of MAGI3 mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 affects the expression of MAGI3 protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of MAGI3 mRNA22100608
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of MAGI3 gene27153756
D000643Ammonium ChlorideAmmonium Chloride affects the expression of MAGI3 mRNA16483693
D001280AtrazineAtrazine results in decreased expression of MAGI3 mRNA25929836
C547126AZM551248AZM551248 results in decreased expression of MAGI3 mRNA22323515
C030935benz(a)anthracene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGI3 mRNA27858113
C006703benzo(b)fluoranthene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGI3 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of MAGI3 mRNA20106945|2163298
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGI3 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of MAGI3 mRNA19770486
C006780bisphenol Abisphenol A results in decreased methylation of MAGI3 promoter27312807
C006780bisphenol Abisphenol A results in increased expression of MAGI3 mRNA25181051
C031180chrysene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGI3 mRNA27858113
D003033Coal TarCoal Tar results in decreased expression of MAGI3 mRNA27858113
D016572CyclosporineCyclosporine results in decreased expression of MAGI3 mRNA25562108
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of MAGI3 mRNA27392435
D002945CisplatinCisplatin results in decreased expression of MAGI3 mRNA27392435
C070609EMD 53998EMD 53998 analog results in decreased expression of MAGI3 mRNA24977338
C118739entinostatentinostat results in decreased expression of MAGI3 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAGI3 mRNA"27188386
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of MAGI3 mRNA17555576
D005485FlutamideFlutamide results in decreased expression of MAGI3 mRNA24793618
D005839GentamicinsGentamicins results in decreased expression of MAGI3 mRNA22061828
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of MAGI3 mRNA27392435
C544151jinfukangjinfukang results in decreased expression of MAGI3 mRNA27392435
C045463leflunomideleflunomide results in increased expression of MAGI3 mRNA28988120
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in increased expression of MAGI3 mRNA"24972896
D008777MethyltestosteroneMethyltestosterone results in decreased expression of MAGI3 mRNA29191790
C583365N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide"N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in decreased expression of MAGI3 mRNA"29244179
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of MAGI3 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of MAGI3 mRNA"25554681
C029938nickel sulfatenickel sulfate results in decreased expression of MAGI3 mRNA22714537
C030110oxaliplatin[oxaliplatin co-treated with Topotecan] results in decreased expression of MAGI3 mRNA25729387
D052638Particulate MatterParticulate Matter results in increased expression of MAGI3 mRNA24769257
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAGI3 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in decreased expression of MAGI3 mRNA26272509
D011192Potassium DichromatePotassium Dichromate results in increased expression of MAGI3 mRNA23608068
D011441PropylthiouracilPropylthiouracil results in increased expression of MAGI3 mRNA24780913
D011794QuercetinQuercetin results in decreased expression of MAGI3 mRNA21632981
D012715Sesame OilSesame Oil results in increased expression of MAGI3 mRNA29191790
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of MAGI3 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of MAGI3 mRNA15328365
D019772Topotecan[oxaliplatin co-treated with Topotecan] results in decreased expression of MAGI3 mRNA25729387
D019772TopotecanTopotecan results in decreased expression of MAGI3 mRNA25729387
C057693troglitazonetroglitazone results in decreased expression of MAGI3 mRNA28973697
D014520UrethaneUrethane results in increased expression of MAGI3 mRNA28818685
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid results in decreased expression of MAGI3 mRNA15885361
D014635Valproic AcidValproic Acid affects the expression of MAGI3 mRNA25979313
C111237vorinostatvorinostat results in decreased expression of MAGI3 mRNA27188386

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0004385guanylate kinase activity-NAS10748157  
GO:0005515protein binding-IPI10748157  16316992  16964398  20353789  
GO:0005524ATP binding-IEA-  
GO:0032947protein-containing complex scaffold activity-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0006915apoptotic process-NAS10748157  
GO:0016032viral process-IEA-  
GO:0035556intracellular signal transduction-NAS10748157  
GO:0046037GMP metabolic process-IEA-  
GO:0046328regulation of JNK cascade-IEA-  
GO:0046710GDP metabolic process-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IEA-  
GO:0005886plasma membrane-IEA-  
GO:0005923bicellular tight junction-IEA-  
GO:0016020membrane-NAS10748157  
GO:0030054cell junction-IDA-  
KEGG ID KEGG Term
hsa04530Tight junction
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
25345847The association of thyroid peroxidase antibody risk loci with susceptibility to and phenotype of Graves' disease. (2015 Oct)Kus AClin Endocrinol (Oxf)